- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07725094
Maternal Sensory Interventions in Newborns (MSI)
24 de julio de 2026 actualizado por: Edanur Tar Bolacali, Kirsehir Ahi Evran Universitesi
The Effect of Maternal Sensory Stimulation (Kangaroo Care, Lullabies, Tactile-Auditory Soothing) on Newborns' Sleep-Wake State and Physiological Parameters: A Randomized Controlled Trial
This study was designed to determine the effects of maternal sensory interventions (kangaroo care, lullabies, and maternal tactile-auditory soothing) on sleep-wake states, physiological parameters, and sleep onset latency in newborns admitted to the neonatal intensive care unit.
Descripción general del estudio
Estado
Aún no reclutando
Intervención / Tratamiento
Descripción detallada
Sleep organization and physiological stability are essential indicators of neurological development and overall health in newborns.
However, newborns hospitalized in neonatal intensive care units (NICUs) are frequently exposed to environmental stressors, including excessive noise, continuous lighting, routine caregiving activities, and medical procedures, which may adversely affect sleep quality and physiological stability.
Maternal sensory interventions are non-pharmacological developmental care approaches that may promote relaxation, improve sleep organization, and support physiological regulation through tactile and auditory stimulation.
This study is designed as a single-center, four-arm, parallel-group randomized controlled trial to evaluate the effects of maternal sensory interventions on sleep-wake states, physiological parameters, and sleep onset latency in newborns admitted to the NICU.
Eligible clinically stable newborns will be randomly assigned in a 1:1:1:1 ratio to one of four groups: kangaroo care, maternal lullaby, maternal tactile-auditory soothing, or routine care (control).
Following routine midday care and feeding, newborns in the kangaroo care group will receive uninterrupted skin-to-skin contact with their mothers for 60 minutes.
In the maternal lullaby group, mothers will sing a lullaby of their choice for 15 minutes.
In the maternal tactile-auditory soothing group, mothers will gently provide rhythmic tactile stimulation to the infant's back and shoulders while simultaneously producing soft rhythmic soothing vocal sounds ("pış pış") for 15 minutes.
Infants in the control group will receive routine NICU care without additional intervention.
All newborns will be monitored for a total of 60 minutes following the intervention or routine care.
Sleep-wake states will be continuously assessed using the Bispectral Index (BIS) monitor.
Physiological parameters, including heart rate, respiratory rate, and oxygen saturation, will be recorded at predetermined time points using standard patient monitoring equipment.
Sleep onset latency, as well as the duration of wakefulness, REM sleep, light sleep, and deep sleep, will be calculated from BIS recordings.
The findings of this study are expected to provide evidence regarding the effectiveness of maternal sensory interventions in improving sleep organization and physiological stability in newborns and to contribute to the development of evidence-based developmental care practices in neonatal intensive care units.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
80
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Edanur Tar Bolacali, PhD
- Número de teléfono: +908504412483
- Correo electrónico: edanurtar.1107@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Sibel Kucukoglu, PhD
- Número de teléfono: +903322231623
- Correo electrónico: s_nadaroglu@hotmail.com
Ubicaciones de estudio
-
-
Kırşehir
-
Kırşehir, Kırşehir, Turquía (Türkiye), 40100
- Kirsehir Ahi Evran Universty
-
Contacto:
- Edanur Tar Bolacalı, PhD
- Número de teléfono: +908504412483
- Correo electrónico: edanurtar.1107@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Gestational age between 35 and 42 completed weeks.
- Birth weight between 2,000 and 4,200 grams.
- Clinically stable newborn admitted to the neonatal intensive care unit.
- Spontaneous breathing without the need for mechanical ventilation.
- Not receiving sedative medications.
- Written informed consent obtained from a parent or legal guardian.
Exclusion Criteria:
- Five-minute Apgar score <4.
- Requirement for advanced resuscitation after birth.
- Presence of a major congenital anomaly.
- Requirement for invasive intervention involving the head region.
- Diagnosed central nervous system dysfunction or neurological disorder.
- Presence of severe postnatal medical complications that may affect study outcomes.
Exclusion Criteria (during the research):
- The newborn develops an unexpected need for resuscitation during the study, as this may adversely affect the central nervous system and consequently influence sleep-wake patterns and study outcomes.
- A parent or legal guardian withdraws consent for the newborn's participation in the study.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention Group 1: Kangaroo Care
Participants assigned to this group will receive kangaroo care provided by their mothers for 60 minutes following routine midday care and feeding.
Sleep-wake states, sleep onset latency, and physiological parameters will be monitored for a total of 60 minutes.
|
Kangaroo care will be provided by the mother for 60 minutes following routine midday care and feeding.
The newborn, wearing only a diaper, will be placed in an upright skin-to-skin position on the mother's bare chest.
The infant's head will be positioned to maintain airway patency, and a light blanket will be used to maintain thermal stability.
Sleep-wake states, sleep onset latency, and physiological parameters will be monitored throughout the 60-minute observation period.
|
|
Experimental: Intervention Group 2: Maternal Lullaby
Participants assigned to this group will receive maternal lullaby intervention for 15 minutes following routine midday care and feeding.
Mothers will sing a lullaby of their choice while the infant remains in the crib.
Sleep-wake states, sleep onset latency, and physiological parameters will be monitored for a total of 60 minutes.
|
Following routine midday care and feeding, mothers will sing a lullaby of their choice to their newborn for 15 minutes while the infant remains in the crib.
The lullaby will be performed in a soft, soothing voice at a sound level not exceeding 45-50 dB.
Sleep-wake states, sleep onset latency, and physiological parameters will be monitored for a total of 60 minutes.
|
|
Experimental: Intervention Group 3: Maternal Tactile-Auditory Soothing
Participants assigned to this group will receive maternal tactile-auditory soothing for 15 minutes following routine midday care and feeding.
Mothers will provide gentle rhythmic tactile stimulation to the infant's back and shoulders while simultaneously producing soft rhythmic soothing vocal sounds ("pış pış").
Sleep-wake states, sleep onset latency, and physiological parameters will be monitored for a total of 60 minutes.
|
Following routine midday care and feeding, mothers will provide gentle rhythmic tactile stimulation by softly stroking the infant's back and shoulders while simultaneously producing soft rhythmic soothing vocal sounds ("pış pış") for 15 minutes.
The sound level will not exceed 45-50 dB.
Sleep-wake states, sleep onset latency, and physiological parameters will be monitored for a total of 60 minutes.
|
|
Sin intervención: Routine Care (Control)
Participants assigned to this group will receive routine neonatal intensive care without any additional sensory intervention.
Sleep-wake states, sleep onset latency, and physiological parameters will be monitored for a total of 60 minutes following routine care.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sleep Onset Latency
Periodo de tiempo: From the beginning of the intervention until sleep onset, assessed within 60 minutes
|
Sleep onset latency will be defined as the time, in minutes, from the beginning of the assigned intervention or routine care until the BIS value first decreases below 91, indicating transition from wakefulness to sleep.
|
From the beginning of the intervention until sleep onset, assessed within 60 minutes
|
|
Sleep-Wake States Assessed by Bispectral Index
Periodo de tiempo: During the 60-minute observation period following routine midday care and feeding
|
Sleep-wake states will be assessed continuously using the Bispectral Index (BIS), a processed electroencephalographic monitoring system with scores ranging from 0 to 100, where higher scores indicate greater wakefulness and lower scores indicate deeper levels of sleep.
BIS values will be classified as wakefulness (91-100), REM sleep (80-90), light sleep (55-79), and deep sleep (0-54).
The duration and percentage of time spent in each sleep-wake state will be calculated during the 60-minute observation period.
|
During the 60-minute observation period following routine midday care and feeding
|
|
Mean Bispectral Index Score
Periodo de tiempo: During the 60-minute observation period
|
The mean Bispectral Index (BIS) score will be calculated from values recorded at one-minute intervals throughout the 60-minute monitoring period.
BIS scores range from 0 to 100, with higher scores indicating greater wakefulness and lower scores indicating deeper sleep.
|
During the 60-minute observation period
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Heart Rate
Periodo de tiempo: Baseline, 15, 30, and 60 minutes after the intervention or routine care
|
Heart rate (beats per minute) will be recorded using the standard patient monitor at baseline (0 minutes) and at 15, 30, and 60 minutes during the observation period.
|
Baseline, 15, 30, and 60 minutes after the intervention or routine care
|
|
Respiratory Rate
Periodo de tiempo: Baseline, 15, 30, and 60 minutes after the intervention or routine care
|
Respiratory rate (breaths per minute) will be recorded using the standard patient monitor at baseline (0 minutes) and at 15, 30, and 60 minutes during the observation period.
|
Baseline, 15, 30, and 60 minutes after the intervention or routine care
|
|
Oxygen Saturation (SpO₂)
Periodo de tiempo: Baseline, 15, 30, and 60 minutes after the intervention or routine care
|
Peripheral oxygen saturation (SpO₂, %) will be measured using the standard patient monitor at baseline (0 minutes) and at 15, 30, and 60 minutes during the observation period.
|
Baseline, 15, 30, and 60 minutes after the intervention or routine care
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
- Caba-Flores MD, Ramos-Ligonio A, Camacho-Morales A, Martinez-Valenzuela C, Viveros-Contreras R, Caba M. Breast Milk and the Importance of Chrononutrition. Front Nutr. 2022 May 12;9:867507. doi: 10.3389/fnut.2022.867507. eCollection 2022.
- Huang Q, Lai X, Liao J, Tan Y. Effect of non-pharmacological interventions on sleep in preterm infants in the neonatal intensive care unit: A protocol for systematic review and network meta-analysis. Medicine (Baltimore). 2021 Oct 29;100(43):e27587. doi: 10.1097/MD.0000000000027587.
- Yasova Barbeau D, Krueger C, Huene M, Copenhaver N, Bennett J, Weaver M, Weiss MD. Heart rate variability and inflammatory markers in neonates with hypoxic-ischemic encephalopathy. Physiol Rep. 2019 Aug;7(15):e14110. doi: 10.14814/phy2.14110.
- intensive care unit. Medicine, 100(43), e27587. https://doi.org/10.1097/md.0000000000027587 Kahraman, A., Başbakkal, Z., & Yalaz, M. (2014). Turkish validity and reliability of the Newborn Comfort Behavior Scale. International Refereed Journal of Nursing Research, 1(2), 1-11.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
15 de agosto de 2026
Finalización primaria (Estimado)
15 de octubre de 2026
Finalización del estudio (Estimado)
30 de diciembre de 2026
Fechas de registro del estudio
Enviado por primera vez
21 de julio de 2026
Primero enviado que cumplió con los criterios de control de calidad
21 de julio de 2026
Publicado por primera vez (Actual)
24 de julio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
27 de julio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
24 de julio de 2026
Última verificación
1 de julio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- KAEU-NICU-2026-01
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .